Zura Bio Limited (ZURA)

NASDAQ: ZURA · Real-Time Price · USD

4.020

+0.030 (0.75%)

At close: Nov 4, 2026, 4:00 PM EST

3.840

-0.180 (-4.48%)

After-hours: Nov 4, 2026, 7:30 PM EST

Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Cash & Equivalents	187.65	109.41	176.5	99.81	1.57	4.72
Cash & Short-Term Investments	187.65	109.41	176.5	99.81	1.57	4.72
Cash Growth	34.98%	-38.01%	76.84%	6269.24%	-66.80%	-
Prepaid Expenses	3.94	2.9	2.25	1.04	0.21	-
Total Current Assets	191.59	112.31	178.74	100.84	1.78	4.72
Property, Plant & Equipment	0.15	0.13	0.09	-	-	-
Long-Term Deferred Charges	-	-	-	-	3.49	-
Other Long-Term Assets	2.88	1.51	0.7	-	-	-
Total Assets	194.63	113.95	179.53	100.84	5.26	4.72

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Accounts Payable	0.76	1.28	0.73	2.75	2.01	0.01
Accrued Expenses	14.93	11.13	9.28	7.55	0.82	-
Short-Term Debt	-	-	-	-	7.76	-
Other Current Liabilities	-	-	9.5	10	4.23	0.03
Total Current Liabilities	16.97	12.41	19.51	20.3	14.82	0.04
Other Long-Term Liabilities	-	-	-	0.99	-	-
Total Liabilities	16.97	12.41	19.51	21.29	14.82	0.04

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Common Stock	0.01	0.01	0.01	0	-	-
Additional Paid-In Capital	478.55	326.08	302.71	162.82	-	-
Retained Earnings	-300.9	-224.55	-155.9	-103.49	-32.06	-7.82
Total Common Equity	177.66	101.54	146.82	59.33	-32.06	-7.82
Minority Interest	-	-	13.2	20.22	10	-
Shareholders' Equity	177.66	101.54	160.02	79.55	-9.56	4.68
Total Liabilities & Equity	194.63	113.95	179.53	100.84	5.26	4.72

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Total Debt	-	-	-	-	7.76	-
Net Cash (Debt)	187.65	109.41	176.5	99.81	-6.19	4.72
Net Cash Growth	34.98%	-38.01%	76.84%	-	-	-
Net Cash Per Share	1.63	1.16	2.35	3.02	-27.13	-
Filing Date Shares Outstanding	96.33	94.88	68.37	43.59	43.09	17.25
Total Common Shares Outstanding	96.31	73.68	65.3	43.59	0.38	17.25
Working Capital	174.62	99.9	159.23	80.54	-13.04	4.68
Book Value Per Share	1.84	1.38	2.25	1.36	-83.59	-0.45
Tangible Book Value	177.66	101.54	146.82	59.33	-32.06	-7.82
Tangible Book Value Per Share	1.84	1.38	2.25	1.36	-83.59	-0.45

SEC Filings: 10-K · 10-Q